Stellar Biotechnologies, Inc V.KLH

SBOTD: Zacks SCR Initiates Coverage of SBOTD With Buy Rec

[notsure]

Today Zacks Small Cap Research Senior Med-Tech Analyst,Brian Marckx, initiated coverage of Stellar Biotechnologies, Inc. with a $13/share price target and Buy recommendation. See below for access to our full 24-page report on the company which includes our financial model, valuation and a comprehensive analysis of SBOTD's proprietary aquaculture technology, manufacturing capabilities, KLH products, markets, competition and commercial opportunities.

https://finance.yahoo.com/news/sbotd-zacks-scr-initiates-coverage-193000720.html

[notsure]

https://scr.zacks.com/files/September-16-2015_SBOTD_Marckx.pdf Link to report

[GovernanceTurd]

This post has been removed in accordance with Community Policy

[PaleRider22]

Great...guess I'll be buying at $6.50 then for a double....

[louel]

I think $6.50 is still high for a reversal to the upside.  I would suggest a bottom of between 2 to $4.     Inttitutional ownership here is onlt .08%  That doesn't show a lot of respect by the big money yet.  Earnings were down 5.9M over 1 year and Book value for the company is only $1.56  Price to sales ratio is 154 which is absurd.     &

[slumdawg]

You may be right and I may be crazy, but, again, we have a company producing KLH and the only one in the world able to raise the Keyhole by aquaculture and extract KLH and not kill the snail allowing a single snail to donate its blood over and over again up to 4 or 5 times a year. The use of the KLH protein goes back to the 50s so that's not new, but but this form of production is

[louel]

There is a lot of difference between MX and KHL.  Not at present even a comparisson MX has been around since 1968,  just short of 50 years.   It is 99.15% institutionally owned.  Not .08 like KLH   MX pays a 25% dividend.   1 year earnings are +$298 Million KLH -$5.9 M    MX is trading at 1.8  x BV     &

[notsure]

Do you own the stock?

[slumdawg]

Yes I do own the stock. About a year now. I appreciate your candid response and I do realize there's a huge difference between MX and KLH. And perhaps the use of the Keyhole will become obsolete in the production of KLH, however, I'm hedging my portfolio to hold a modest position in Stellar with anticipation that their business model will some day soon prove to be profitable and

[louel]

No KLH will not become obsolete.   I is the factor that enhances the immune system.    So far it is still the best known carrier.       What I attemped ti imply is,   Stellar Bio the company has a pattent on one avenue of supply of the adjuvant (serum) which is derived from the limpet.   Their pattents are effective in